To include your compound in the COVID-19 Resource Center, submit it here.

Catena: Extension study data

The open-label, Belgian Phase II DELPHI-E extension study in 19 patients from the Phase II DELPHI trial showed that Catena for 2 years

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE